about
DNA Damage in Chronic Kidney Disease: Evaluation of Clinical BiomarkersAwareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKDConsidering renal risk while managing cancer.A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directionsTest performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol.Importance of pre-transplant colonoscopy in renal transplant recipientsCKD and the risk of incident cancer.Comparison of estimated glomerular filtration rate by the chronic kidney disease epidemiology collaboration (CKD-EPI) equations with and without Cystatin C for predicting clinical outcomes in elderly women.Estimated radiation exposure from medical imaging in hemodialysis patientsCancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients.Cancer risk in East Asian patients associated with acquired haemolytic anaemia: a nationwide population-based cohort studyEnd stage and chronic kidney disease: associations with renal cancer.Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies.Cause-Specific Deaths in Non-Dialysis-Dependent CKDEnd Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population.Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment.An observational study of the quality of care for chronic kidney disease: a Buffalo and Albany, New York metropolitan area study.Chronic kidney disease and cancer: a troubling connectionHepatocellular carcinoma in patients with chronic kidney diseaseCirculating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)Cancer in the transplant recipient.Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years.Patients with heart failure have an increased risk of incident cancer.Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)The association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney diseaseSurvival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management.Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan.Dialyzer reuse and mortality risk in patients with end-stage renal disease: a systematic review.Oncological and renal medical importance of kidney-sparing surgery.Noncardiovascular mortality in CKD: an epidemiological perspective.Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN).Renal cancer in kidney transplanted patients.Nephro-oncology: a link in evolution.Low white blood cell count is independently associated with chronic kidney disease progression in the elderly: the CKD-ROUTE study.Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.Association of erythropoiesis-stimulating agents and the incidence risk of cancer diagnosis among chronic dialysis patients: a nested case-control study.Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.Prevalence of various comorbidities among veterans with chronic kidney disease and its comparison with other datasets.[Urological follow-up and development of cancer after renal transplantation].
P2860
Q26744636-93D3A654-FA5F-4986-9D97-A08A2F94DE01Q28468296-8619DE49-D972-45B9-8944-BCD2089889BCQ30234338-C998AEE6-20FD-4808-9625-A9223FC432FFQ30491777-CBCCB5C3-332A-4697-B805-C665855629ABQ33945977-D895E391-D288-4FDA-A26C-468FCD807559Q34213004-B06CDAF4-83B1-4805-A97D-D1647CCFF4A1Q34259993-7B3F997C-2F10-435F-B384-EF6904549EEDQ34267914-0F5849CC-A9A6-4DBC-B302-B4705EC94B31Q34695442-00B55524-8E56-4FA5-84B9-9F4BFB5DCCC8Q34927050-278FFE84-C63F-4212-9740-419995B29093Q35597739-AAC26C9A-D2C5-4C9B-B2E8-CB822FC4E30DQ35914916-9061B42B-6734-4018-A055-127FACAE0802Q35971255-3AF8E388-7F7B-4774-A254-FDE5E3060B2DQ36078969-325CFA4F-45D0-410F-A731-E72964CB2E0BQ36104882-44A9FEEF-5244-4916-B17E-8FF7852A9479Q36187274-4E7C4F1E-6959-4678-A786-0C1AFC18F9B2Q36227525-2C5AF0F3-45FF-468C-BCC8-A2F898CE43C0Q36346721-346BD72E-2E76-4DA2-B2DC-C8588ADFEAB1Q36773023-2723FB36-B4E2-4D2F-8F1E-A61A08BCAED2Q36821615-7CDA9D8E-2CD4-4855-ADD3-2647534F6515Q36918121-FFD46517-133D-4731-AABE-137A849ED98AQ36938488-2916706D-E2B7-4AB0-AA84-D78982474681Q37001231-10740E30-7F16-4912-B164-7D15847B3109Q37136235-879C8C8B-8CDD-42E3-A33F-8835CD47FCAFQ37201197-395B1615-0CC6-493A-B49D-1C5671254682Q37464712-A344287F-2331-48F9-88A2-E97BC5E99ABDQ37482444-BA552E3F-87BE-4563-BB70-70C64F09A9D7Q37604298-54E992FA-D731-4F0F-A3CD-B29E9E6EE96AQ37986995-78A1FBB7-FF6E-44BD-82B4-09ED6E472E0EQ38086375-51351C57-E011-4194-9AE0-1000F969D0D9Q38184840-A93D4F90-15A7-46BA-AE1F-A89BC62D1406Q38367232-B6D8046C-E25D-44A7-B6BE-93C9B82A36A0Q38552310-6200590F-1D66-4735-96A7-167C05CCA3C2Q38554467-BEC2BB56-6FDE-4A9C-9C9B-C24C47CD1AB9Q38683105-740AAC05-057A-468C-A838-8C8A5F58401CQ38808544-438FB3B1-477F-47A0-A0BA-4F5A004856F2Q39569552-F5F71884-435C-43ED-ABEF-F69E2B64FA3DQ39904893-5D5D939E-E1D7-4E08-8F7D-9DFCE2FAF8A6Q40208226-D48EC793-65AA-4837-AB28-7A07D9CB8071Q40956112-7AE30151-3B5D-474B-8343-6CB5647C3233
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of CKD and cancer risk in older people
@en
Association of CKD and cancer risk in older people.
@nl
type
label
Association of CKD and cancer risk in older people
@en
Association of CKD and cancer risk in older people.
@nl
prefLabel
Association of CKD and cancer risk in older people
@en
Association of CKD and cancer risk in older people.
@nl
P2093
P2860
P50
P356
P1476
Association of CKD and cancer risk in older people
@en
P2093
Jeremy R Chapman
Jie Jin Wang
Paul Mitchell
P2860
P304
P356
10.1681/ASN.2008090998
P577
2009-04-30T00:00:00Z